Narrow search
Showing 1 - 10 of 904
Cover Image
Science, Scarcity and Public Health : The Search for New Pharma Models
Abbott, Frederick M. - 2015
These are neither the best of times nor the worst of times for the pharmaceutical industry, or for global public health. Media reports regarding recent legal developments would suggest that the originator pharmaceutical industry is facing a new and dangerous threat to its long-term welfare,...
Persistent link: https://www.econbiz.de/10014141859
Cover Image
Negotiation as a means of developing and implementing health and safety policy
Caldart, Charles C.; Ashford, Nicholas Askounes - 1998
In the health, safety, and environmental area, negotiated rulemaking, implementation, and compliance are proposed by their advocates as delivering two primary benefits: reduced rulemaking time and decreased litigation over a final agency rule. The experience to date, however, indicates that...
Persistent link: https://www.econbiz.de/10011608406
Cover Image
On the design of equity-oriented pharmaceutical copayments
González, Paula - In: SERIEs : Journal of the Spanish Economic Association 11 (2020) 2, pp. 179-202
In this paper, we propose a new approach to address the problem of designing pharmaceutical copayments. The rationale … for positive copayments in our setting lies in the presence of budgetary constraints and, hence, in the need to raise … claims to incorporate criteria of distributive justice into the design of copayments. We find that if the government …
Persistent link: https://www.econbiz.de/10012240615
Cover Image
Warum und wie die Liberalisierung des Cannabismarktes in Deutschland erfolgen sollte
Haucap, Justus; Knoke, Leon - In: Wirtschaftsdienst : Zeitschrift für Wirtschaftspolitik 102 (2022) 1, pp. 32-39
Der vorliegende Beitrag fasst die Argumente für eine Legalisierung von Cannabis zusammen und macht Vorschläge zur Ausgestaltung des Regulierungsrahmens. Hauptargument für eine regulierte Cannabisfreigabe sind nicht die zu erwartenden Steuereinnahmen oder die entstehenden legalen...
Persistent link: https://www.econbiz.de/10012813400
Cover Image
Servitization Strategies in Pharmochemistry Firms of Nutrition and Animal Health in Argentina
Lepratte, Leandro; Blanc, Rafael L.; Hegglin, Daniel R.; … - 2019
The servitization in manufacturing firms has gained relevance in recent years. In the pharmochemistry industry of nutrition and animal health, these types of strategies have been little explored, particularly those that incorporate knowledge-intensive business services in veterinary and...
Persistent link: https://www.econbiz.de/10014104116
Cover Image
Inquiry into the Impact of Bush's Executive Order 13211 on Environmental and Public Health Regulation
Geltman, Elizabeth - 2016
Executive Order 13211, promulgated in 2001, requires the federal government to consider the impact of federal action on energy independence as part of the George W. Bush's National Energy Policy. This law review examines whether EO 13211 was used to curtail environmental protection and natural...
Persistent link: https://www.econbiz.de/10012998908
Cover Image
Influencer la recherche pharmaceutique : un enjeu pour la connaissance des pathologies. Le cas de l'hypercholestérolémie et des statines
Bonetti, Emmanuelle - In: Revue d'économie industrielle n° 120 (2007) 4, pp. 12-12
The aim of this paper is to show that the conception of drugs orientates the disease?s knowledge. We will demonstrate this proposition with regard to the hypercholesterolemia?s story. In the first place, we?ll see that the elaboration of treatments fully participates to the evolution of the...
Persistent link: https://www.econbiz.de/10011020540
Cover Image
Who Has to Pay More, Health Service Sectors, the Pharmaceutical Industry, or Future Generations? A Computable General Equilibrium Approach
Kato, Ryuta Ray - Graduate School of International Relations, … - 2011
This paper presents a computable general equilibrium (CGE) framework to numerically examine the effect of tax/subsidy reforms of health related sectors. The generalized framework with the latest Japanese input-output table of year 2005 with 108 different production sectors provides the following...
Persistent link: https://www.econbiz.de/10010627383
Cover Image
De dónde viene y a dónde va el financiamiento para la salud mundial
Velásquez, Germán - 2023
In theory, the WHO is the coordinating agency for global health, and large private and public actors claim the relevance and central role of this UN agency. In practice, paradoxically, the money for health goes largely to other institutions and not to the WHO, or even new institutions or...
Persistent link: https://www.econbiz.de/10014374571
Cover Image
Where does global health funding come from and where does it go?
Velásquez, Germán - 2023
In theory, the WHO is the coordinating agency for global health, and large private and public actors claim the relevance and central role of this UN agency. In practice, paradoxically, the money for health goes largely to other institutions and not to the WHO, or even new institutions or...
Persistent link: https://www.econbiz.de/10014374572